KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Becton Dickinson (BDX) Research & Development (2016 - 2025)

Becton Dickinson (BDX) has disclosed Research & Development for 17 consecutive years, with $306.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development fell 10.79% to $306.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 1.21% decrease, with the full-year FY2025 number at $1.3 billion, up 6.3% from a year prior.
  • Research & Development was $306.0 million for Q4 2025 at Becton Dickinson, down from $322.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $343.0 million in Q4 2024 to a low of $280.0 million in Q3 2023.
  • A 5-year average of $312.1 million and a median of $309.5 million in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: skyrocketed 40.91% in 2021, then decreased 12.02% in 2022.
  • Becton Dickinson's Research & Development stood at $314.0 million in 2021, then decreased by 0.32% to $313.0 million in 2022, then dropped by 7.35% to $290.0 million in 2023, then grew by 18.28% to $343.0 million in 2024, then fell by 10.79% to $306.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDX's Research & Development are $306.0 million (Q4 2025), $322.0 million (Q3 2025), and $297.0 million (Q2 2025).